The population genetics of pathogenic Escherichia coli

E Denamur, O Clermont, S Bonacorsi… - Nature Reviews …, 2021 - nature.com
Escherichia coli is a commensal of the vertebrate gut that is increasingly involved in various
intestinal and extra-intestinal infections as an opportunistic pathogen. Numerous pathotypes …

Escherichia coli Mastitis in Dairy Cattle: Etiology, Diagnosis, and Treatment Challenges

DB Goulart, M Mellata - Frontiers in Microbiology, 2022 - frontiersin.org
Bovine mastitis is an inflammation of the udder tissue parenchyma that causes pathological
changes in the glandular tissue and abnormalities in milk leading to significant economic …

[HTML][HTML] Gut microbiota imbalance and colorectal cancer

J Gagnière, J Raisch, J Veziant, N Barnich… - World journal of …, 2016 - ncbi.nlm.nih.gov
The gut microbiota acts as a real organ. The symbiotic interactions between resident micro-
organisms and the digestive tract highly contribute to maintain the gut homeostasis …

Escherichia coli ST131, an intriguing clonal group

MH Nicolas-Chanoine, X Bertrand… - Clinical microbiology …, 2014 - Am Soc Microbiol
In 2008, a previously unknown Escherichia coli clonal group, sequence type 131 (ST131),
was identified on three continents. Today, ST131 is the predominant E. coli lineage among …

The Clermont Escherichia coli phylo‐typing method revisited: improvement of specificity and detection of new phylo‐groups

O Clermont, JK Christenson… - Environmental …, 2013 - Wiley Online Library
There is extensive genetic substructure within the species E scherichia coli. In 2000 a simple
triplex PCR method was described by C lermont and colleagues that enables an E. coli …

Pathogenicity Factors of Genomic Islands in Intestinal and Extraintestinal Escherichia coli

M Desvaux, G Dalmasso, R Beyrouthy… - Frontiers in …, 2020 - frontiersin.org
Escherichia coli is a versatile bacterial species that includes both harmless commensal
strains and pathogenic strains found in the gastrointestinal tract in humans and warm …

Targeting virulence: can we make evolution-proof drugs?

RC Allen, R Popat, SP Diggle, SP Brown - Nature Reviews Microbiology, 2014 - nature.com
Antivirulence drugs are a new type of therapeutic drug that target virulence factors,
potentially revitalising the drug-development pipeline with new targets. As antivirulence …

The population genetics of commensal Escherichia coli

O Tenaillon, D Skurnik, B Picard… - Nature reviews …, 2010 - nature.com
The primary habitat of Escherichia coli is the vertebrate gut, where it is the predominant
aerobic organism, living in symbiosis with its host. Despite the occurrence of recombination …

Gut microbiota in colorectal cancer: biological role and therapeutic opportunities

H Pandey, DWT Tang, SH Wong, D Lal - Cancers, 2023 - mdpi.com
Simple Summary Colorectal cancer (CRC) is the second-leading cause of cancer-related
deaths worldwide. In this review article, we examine the role of gut microbiota in the …

E. coli as an All-Rounder: The Thin Line Between Commensalism and Pathogenicity

A Leimbach, J Hacker, U Dobrindt - Between pathogenicity and …, 2013 - Springer
Escherichia coli is a paradigm for a versatile bacterial species which comprises harmless
commensal as well as different pathogenic variants with the ability to either cause intestinal …